StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report report published on Thursday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright increased their price objective on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
Get Our Latest Analysis on SenesTech
SenesTech Price Performance
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- Investing In Preferred Stock vs. Common Stock
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to trade using analyst ratings
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.